Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 651–700 of 76231
the following individuals, each of whom was a member of the board of directors of Northfield Bancorp immediately prior to the Effective Time, were appointed to the board of directors of Columbia Financial and Columbia Bank: Steven M. Klein, John P. Connors, Jr., Timothy C. Harrison and Paul V. Stahlin.
As of the Effective Time, and pursuant to the terms of the Merger Agreement, Northfield Bancorp’s directors and executive officers ceased serving as directors and executive officers of Northfield Bancorp.
the following individuals, each of whom was a member of the board of directors of Northfield Bancorp immediately prior to the Effective Time, were appointed to the board of directors of Columbia Financial and Columbia Bank: Steven M. Klein, John P. Connors, Jr., Timothy C. Harrison and Paul V. Stahlin.
the following individuals, each of whom was a member of the board of directors of Northfield Bancorp immediately prior to the Effective Time, were appointed to the board of directors of Columbia Financial and Columbia Bank: Steven M. Klein, John P. Connors, Jr., Timothy C. Harrison and Paul V. Stahlin.
As of the Effective Time, and pursuant to the terms of the Merger Agreement, Northfield Bancorp’s directors and executive officers ceased serving as directors and executive officers of Northfield Bancorp.
As of the Effective Time, and pursuant to the terms of the Merger Agreement, Northfield Bancorp’s directors and executive officers ceased serving as directors and executive officers of Northfield Bancorp.
Steven M. Klein, the Chairman, President and Chief Executive Officer of Northfield Bancorp, was appointed as Senior Executive Vice President and Chief Operating Officer of Columbia Financial and Columbia Bank effective as of the Effective Time.
As of the Effective Time, and pursuant to the terms of the Merger Agreement, Northfield Bancorp’s directors and executive officers ceased serving as directors and executive officers of Northfield Bancorp.
J. Ted Nissen has notified the Company and the Bank of his decision to retire from his positions as Executive Vice President and Chief Banking Officer of the Company and President and Chief Executive Officer of the Bank, effective December 31, 2026.
Mr. Nissen will also retire from the boards of directors of the Company and the Bank, effective December 31, 2026.
On July 21, 2026, Mr. Dozier and Mr. Painter were appointed to the boards of directors of the Company and the Bank, effective January 1, 2027.
Vaughan R. Dozier, Jr., age 45, will become Chief Executive Officer of the Bank and Joseph A. “Drew” Painter, age 48, will become President of the Bank, each effective January 1, 2027.
Joseph A. “Drew” Painter, age 48, will become President of the Bank, each effective January 1, 2027.
On July 21, 2026, Mr. Dozier and Mr. Painter were appointed to the boards of directors of the Company and the Bank, effective January 1, 2027.
On or about July 1, 2026, the Board of Directors (the “ Board ”) of BluSky AI Inc. (the “ Company ”) appointed Mort Aaronson as a member of the Board to fill a vacancy on the Board.
appointed Matthew Kreps to the Board to serve as a director
On July 21, 2026, Stephen Lee resigned from the Board of Directors (the “Board”) of Prairie Operating Co. (the “Company”).
On July 21, 2026, the Board elected Jennifer Grigsby as a member of the Board, filling the vacancy occurring due to the resignation of Mr. Lee.
David C. Dennsteadt has been named President and Chief Operating Officer of the Company, effective as of July 17, 2026.
Immediately following such dissolution, the following individuals were appointed directors of Reorganized GoHealth: Vijay Kotte, Scott Avila, Neal Goldman and Conor Colpoys .
Immediately following such dissolution, the following individuals were appointed directors of Reorganized GoHealth: Vijay Kotte, Scott Avila, Neal Goldman and Conor Colpoys .
Immediately following such dissolution, the following individuals were appointed directors of Reorganized GoHealth: Vijay Kotte, Scott Avila, Neal Goldman and Conor Colpoys .
Immediately following such dissolution, the following individuals were appointed directors of Reorganized GoHealth: Vijay Kotte, Scott Avila, Neal Goldman and Conor Colpoys .
On July 17, 2026, the board of directors (the “Board”) of Upland Software, Inc. (the “Company”) appointed Jennifer Simon to serve as Chief Financial Officer of the Company, effective as of August 17, 2026 (the “Effective Date”).
Mr. Stehlin resigned as the Chief Executive Officer of the Company (“CEO”), effective immediately following execution of the Agreement.
Effective immediately following execution of the Agreement on July 17, 2026, each of the New Directors were appointed to serve as a member of the Board as a Class I, Class II and Class III director, respectively, with an initial term expiring at the Company’s 2026 annual general meeting of shareholders to fill the vacancies resulting from the resignations of the Departing Directors.
the Departing Directors submitted irrevocable resignations from the Board and all positions with the Company and its subsidiaries, effective immediately following execution of the Agreement.
Effective immediately following execution of the Agreement on July 17, 2026, each of the New Directors were appointed to serve as a member of the Board as a Class I, Class II and Class III director, respectively, with an initial term expiring at the Company’s 2026 annual general meeting of shareholders to fill the vacancies resulting from the resignations of the Departing Directors.
Effective immediately following execution of the Agreement on July 17, 2026, each of the New Directors were appointed to serve as a member of the Board as a Class I, Class II and Class III director, respectively, with an initial term expiring at the Company’s 2026 annual general meeting of shareholders to fill the vacancies resulting from the resignations of the Departing Directors.
Mr. Borenstein was appointed as the Chair of the Board.
On July 21, 2026, Mr. Rozenbaum was appointed as the Interim CEO of the Company.
On July 20, 2026, the Board of Directors (the “Board”) of CrossAmerica GP LLC, the general partner (the “General Partner”) of CrossAmerica Partners LP (“CrossAmerica” or the “Partnership”), appointed Jonathan E. Benfield to serve as Chief Financial Officer of the General Partner, effective immediately.
On July 21, 2026, the Fulton Financial Corporation (“Fulton”) board of directors (the “Board”) elected David S. Schulz (“Mr. Schulz”), age 60, to the Board for a term commencing September 14, 2026 and expiring at Fulton’s 2027 annual meeting of shareholders.
each of the members of the Board (Joseph Doherty, Stephen From, Adam Sachs, Sammy Khalifa, David Ho, Victoria Carr-Brendel, and Fuad Ahmad), each provided notice of his or her decision to resign from the Board and all committees thereof, effective upon the filing of the Form 15 with the Securities and Exchange Commission (the “SEC”).
each of the members of the Board (Joseph Doherty, Stephen From, Adam Sachs, Sammy Khalifa, David Ho, Victoria Carr-Brendel, and Fuad Ahmad), each provided notice of his or her decision to resign from the Board and all committees thereof, effective upon the filing of the Form 15 with the Securities and Exchange Commission (the “SEC”).
the Company terminated the employment of each of Stephen From, the Company’s Chief Executive Officer, Adam Sachs, the Company’s President, Sammy Khalifa, the Company’s Chief Technology Officer, and Dr. Barry Greene, the Company’s Chief Medical Officer, effective as of the close of business on July 21, 2026.
the Company terminated the employment of each of Stephen From, the Company’s Chief Executive Officer, Adam Sachs, the Company’s President, Sammy Khalifa, the Company’s Chief Technology Officer, and Dr. Barry Greene, the Company’s Chief Medical Officer, effective as of the close of business on July 21, 2026.
each of the members of the Board (Joseph Doherty, Stephen From, Adam Sachs, Sammy Khalifa, David Ho, Victoria Carr-Brendel, and Fuad Ahmad), each provided notice of his or her decision to resign from the Board and all committees thereof, effective upon the filing of the Form 15 with the Securities and Exchange Commission (the “SEC”).
each of the members of the Board (Joseph Doherty, Stephen From, Adam Sachs, Sammy Khalifa, David Ho, Victoria Carr-Brendel, and Fuad Ahmad), each provided notice of his or her decision to resign from the Board and all committees thereof, effective upon the filing of the Form 15 with the Securities and Exchange Commission (the “SEC”).
each of the members of the Board (Joseph Doherty, Stephen From, Adam Sachs, Sammy Khalifa, David Ho, Victoria Carr-Brendel, and Fuad Ahmad), each provided notice of his or her decision to resign from the Board and all committees thereof, effective upon the filing of the Form 15 with the Securities and Exchange Commission (the “SEC”).
each of the members of the Board (Joseph Doherty, Stephen From, Adam Sachs, Sammy Khalifa, David Ho, Victoria Carr-Brendel, and Fuad Ahmad), each provided notice of his or her decision to resign from the Board and all committees thereof, effective upon the filing of the Form 15 with the Securities and Exchange Commission (the “SEC”).
the Company terminated the employment of each of Stephen From, the Company’s Chief Executive Officer, Adam Sachs, the Company’s President, Sammy Khalifa, the Company’s Chief Technology Officer, and Dr. Barry Greene, the Company’s Chief Medical Officer, effective as of the close of business on July 21, 2026.
the Company terminated the employment of each of Stephen From, the Company’s Chief Executive Officer, Adam Sachs, the Company’s President, Sammy Khalifa, the Company’s Chief Technology Officer, and Dr. Barry Greene, the Company’s Chief Medical Officer, effective as of the close of business on July 21, 2026.
each of the members of the Board (Joseph Doherty, Stephen From, Adam Sachs, Sammy Khalifa, David Ho, Victoria Carr-Brendel, and Fuad Ahmad), each provided notice of his or her decision to resign from the Board and all committees thereof, effective upon the filing of the Form 15 with the Securities and Exchange Commission (the “SEC”).
On July 20, 2026, Dr. Gregory M. Sullivan informed Tonix Pharmaceuticals Holding Corp. (the “Company”) that he will retire from his role as Chief Medical Officer of the Company, effective August 20, 2026.
On July 16, 2026, Kara Wilson notified the Board of Directors (the “Board”) of Paychex, Inc. (the “Company”) of her decision not to stand for re-election at the Company’s annual meeting of stockholders in 2026 (the “Annual Meeting”).
the Board has elected Bina Mehta to serve as a director on the Board until her successor is duly elected and qualified or her earlier death, disability, resignation or removal.
On July 20, 2026, the Board of Directors (the “Board”) of MediaCo Holding Inc. (the “Company”) appointed Brian Fisher as President of the Company, effective immediately.
Effective on July 17, 2026, Debra DeFelice no longer serves as Chief Financial Officer (“CFO”), Treasurer, and Executive Vice President of the Company.
The Board appointed Roberto Castro as interim CFO and interim Treasurer on July 20, 2026.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.